Enzyme may get key role in drug design for breast cancer and brain condition

(University of Copenhagen The Faculty of Health and Medical Sciences) In recent years, researchers have focused on the enzyme TLK2 suspecting it of playing a main role in several diseases. A new study conducted at the University of Copenhagen now reveals that the enzyme displays lower levels of activity in intellectual disability and that it is possible to inhibit it in breast cancer, where it is overactive. The study thus suggests that the enzyme may be a target for potential therapies.
Source: EurekAlert! - Biology - Category: Biology Source Type: news